Calcium channel blockers are safe, affordable, and effective—making them the ideal first-line hypertension treatment to drive global control efforts in low-resource settings.
Nearly one in four people living with HIV also have hypertension, underscoring the importance of integrating hypertension care into routine HIV services to support better long-term health outcomes.
Why medicine access remains a barrier to many living with high blood pressure and how governments and donors can help bridge the gap and keep blood pressure under control.